In the world of general practice and dentistry, partnerships are often built on longstanding, close-knit relationships. However, even in the most collaborative practices, personal and professional dynamics can sometimes break down beyond repair.

Legal considerations and practical tips for businesses in the pharmaceuticals and life sciences sector.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is developing a new strategy to provide its direction, mission, values and focus through to 2030. What should we expect?

It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

The Court of Appeal has confirmed that umbrella companies cannot treat separate assignments as a single continuous employment for tax purposes and that a failure to take proper advice on contractual arrangements can amount to carelessness leading to a loss of tax.

The Primary Care UMF offers an opportunity for GP practices to improve their premises. Securing the grant requires navigating complex legal agreements. Act promptly to meet these requirements to ensure your practice benefits from this investment.